Word: anthrax
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...post who always wanted a daughter: the baby sitter paints a room in her home pink and smiles when the baby calls her Mama, even when Mother is in the room. It is Laura Richardson's dad, a 68-year-old pediatrician, wondering whether he should get smallpox and anthrax vaccines, so that if his kids were in trouble he could get on a plane and help them. "I thought I could go over if one of my children was horribly maimed or something like that," he says...
OCTOBER 16, 2001 Summers’ first Faculty meeting as University president came in the shadow of the Sept. 11 attacks. Summers said he would establish an “informal advisory group” of faculty and administrators to address the anthrax scare that was gripping the nation...
Corey M. Rennell ’07 will soon boast more than climbing Mt. Kilimanjaro, the highest peak in Africa, and surviving anthrax contracted from a sheep as among his feats. Rennell will be one of six participants in an upcoming reality TV show produced by BBC and The Discovery Channel. Rennell said he will receive $10,000 for participating in the program. Rennell was one of over 100 Americans who applied for the show, according to Louisa M. Griffith-Jones, associate producer for the BBC. The program will feature three American and three British male athletes who will spend...
...part to the long and torturous contracting process. Under BioShield, HHS has paid $5.7 million to buy black raspberry--flavored liquid potassium iodide, a child's version of a pill intended to protect against radioactive iodide in a dirty bomb. The agency is also spending $2.2 million on experimental anthrax treatments (although that money is not coming from the BioShield fund), and a contract for a new smallpox vaccine is expected in 2006. But more than a year into the program, drug companies still complain that they don't have a clear sense of what to develop and how much...
...pharmaceutical and biotech firms want nothing to do with developing biodefense drugs. The little companies that are vying for deals say they are being stymied by an opaque and glacially slow contracting process. The one big contract that has been awarded--for 75 million doses of a next-generation anthrax vaccine--is tangled in controversy; it went to a California firm, VaxGen, which in its 10-year history has never brought a drug to market. In the scientific community, biodefense is viewed as yet another boondoggle that is sucking money and resources from critical public-health needs like new antibiotics...